Catheter ablation of atrial fibrillation in patients with diabetes mellitus.
Atrial fibrillation
Catheter ablation
Diabetes mellitus
Glycemic control
Outcomes
Journal
Heart rhythm O2
ISSN: 2666-5018
Titre abrégé: Heart Rhythm O2
Pays: United States
ID NLM: 101768511
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
entrez:
11
6
2021
pubmed:
12
6
2021
medline:
12
6
2021
Statut:
epublish
Résumé
Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM. The purpose of this study was to compare AF ablation outcomes in patients with and those without DM. We performed a retrospective analysis of 351 consecutive patients who underwent first-time AF ablation. Clinical outcomes included freedom from recurrent atrial arrhythmia, symptom burden (Mayo AF Symptom Inventory score), cardiovascular and all-cause hospitalizations, and periprocedural complications. Patients with DM (n = 65) were older, had a higher body mass index, more persistent AF, more hypertension, and larger left atrial diameter ( Although safety outcomes associated with AF ablation were similar between patients with and those without DM, arrhythmia-free survival was significantly lower among patients with DM. Poor glycemic control seems to an important risk factor for AF recurrence.
Sections du résumé
BACKGROUND
BACKGROUND
Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM.
OBJECTIVE
OBJECTIVE
The purpose of this study was to compare AF ablation outcomes in patients with and those without DM.
METHODS
METHODS
We performed a retrospective analysis of 351 consecutive patients who underwent first-time AF ablation. Clinical outcomes included freedom from recurrent atrial arrhythmia, symptom burden (Mayo AF Symptom Inventory score), cardiovascular and all-cause hospitalizations, and periprocedural complications.
RESULTS
RESULTS
Patients with DM (n = 65) were older, had a higher body mass index, more persistent AF, more hypertension, and larger left atrial diameter (
CONCLUSION
CONCLUSIONS
Although safety outcomes associated with AF ablation were similar between patients with and those without DM, arrhythmia-free survival was significantly lower among patients with DM. Poor glycemic control seems to an important risk factor for AF recurrence.
Identifiants
pubmed: 34113872
doi: 10.1016/j.hroo.2020.04.006
pii: S2666-5018(20)30038-6
pmc: PMC8183889
doi:
Types de publication
Journal Article
Langues
eng
Pagination
180-188Informations de copyright
© 2020 Heart Rhythm Society. Published by Elsevier Inc.
Références
J Cardiovasc Electrophysiol. 2009 Jan;20(1):22-8
pubmed: 18775050
Am J Cardiol. 2011 Jul 1;108(1):56-62
pubmed: 21529739
Am J Cardiol. 2010 Dec 1;106(11):1615-20
pubmed: 21094363
J Am Coll Cardiol. 2017 Sep 12;70(11):1325-1335
pubmed: 28882229
J Am Coll Cardiol. 2014 Dec 2;64(21):2222-31
pubmed: 25456757
J Am Coll Cardiol. 2019 Aug 27;74(8):1107-1115
pubmed: 31439220
Europace. 2015 Oct;17(10):1518-25
pubmed: 26498716
Heart Rhythm. 2018 May;15(5):651-657
pubmed: 29222043
Heart Rhythm. 2008 Nov;5(11):1501-7
pubmed: 18842464
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
PLoS One. 2018 Aug 30;13(8):e0197245
pubmed: 30161122
Eur Heart J. 2009 May;30(9):1128-35
pubmed: 19282274
JAMA. 1994 Mar 16;271(11):840-4
pubmed: 8114238
Heart Rhythm. 2017 Oct;14(10):e275-e444
pubmed: 28506916
JACC Clin Electrophysiol. 2019 Aug;5(8):897-903
pubmed: 31439289
Europace. 2011 Sep;13(9):1256-61
pubmed: 21551479
Am J Cardiol. 2020 Mar 15;125(6):901-906
pubmed: 31973808
J Am Coll Cardiol. 2010 May 25;55(21):2308-16
pubmed: 20488300
J Interv Card Electrophysiol. 2006 Oct;17(1):41-6
pubmed: 17235682